Results 121 to 130 of about 9,786 (244)

Deferasirox pharmacokinetics in patients with adequate versus inadequate response [PDF]

, 2009
Deborah Chirnomas, Amber Lynn Smith, Jennifer Braunstein, Yaron Finkelstein, Luis M. Pereira, Anke Bergmann, Frederick D. Grant, Carole Paley, Michael Shannon, Ellis J. Neufeld   +9 more
openalex   +1 more source

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia: the ESCALATOR study [PDF]

, 2009
Alì Taher, Amal El‐Beshlawy, Mohsen Saleh Elalfy, Kusai Al Zir, Shahina Daar, Dany Habr, Ulrike Kriemler‐Krahn, Abdel Hmissi, Abdullah Al Jefri   +8 more
openalex   +1 more source

Deferasirox treatment may be associated with reversible renal Fanconi syndrome [PDF]

, 2009
Ehud Even‐Or, Rachel Becker‐Cohen, Hagit Miskin   +2 more
openalex   +1 more source

What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis

Therapeutics and Clinical Risk Management, 2018
Carmen Fucile,1 Francesca Mattioli,1 Valeria Marini,1 Massimo Gregori,2 Aurelio Sonzogni,3 Antonietta Martelli,1 Natalia Maximova4 1Pharmacology and Toxicology Unit, University of Genoa, Genoa, Italy; 2Department of Pediatric Radiology, Institute for ...
Fucile C, Mattioli F, Marini V, Gregori M, Sonzogni A, Martelli A, Maximova N   +6 more
doaj  

Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease [PDF]

, 2016
AVILIA, SIMONA, CATALANO, LUCIO, CERCHIONE, CLAUDIO, Cerciello, Giuseppe, DELLA PEPA, ROBERTA, Pane, Fabrizio, PICARDI, MARCO, PUGLIESE, NOVELLA   +7 more
core   +1 more source

Hubungan Derajat Klinis dengan Kadar Feritin Penyandang Thalassemia Β di RSUD Arifin Achmad [PDF]

, 2016
Thalassemia is a genetic disorder which there is interference with the synthesis of hemoglobin that causes a decreased of synthesis of α or β chain, If the abnormalities are β chain called β thalassemia.
Ridar, E. (Elmi), Satria, A. (Adriyan), Tampubolon, L. (Lucyana)   +2 more
core  

Management of Transfusional Chronic Iron Overload: Focus on Deferasirox [PDF]

, 2009
Federica Pilo, Anna Angela Di Tucci, Laura Dessì, Emanuele Angelucci   +3 more
openalex   +1 more source

Effects of chelators (desferal, deferiprone & deferaairox) on the growth of klebsiella and aeromonas isolated from transfusion dependent thalassemia patients [PDF]

, 2010
Poster Presentation (Doctor’s Session)Infection is among the leading causes of death for thalassemia major patients. The known predisposing factors of infection include prior splenectomy, iron overload and use of iron chelator such as desferal ...
Chan, GCF, Chan, S, Ha, SY, Ho, PL
core  

A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE -Related Hereditary Hemochromatosis [PDF]

, 2010
Pradyumna D. Phatak, Pierre Brissot, Mark Wurster, Paul C. Adams, Herbert L. Bonkovsky, John Gross, Peter Malfertheiner, Gordon D. McLaren, Claus Niederau, Alberto Piperno, Lawrie W. Powell, Mark W. Russo, Ulrich Stoelzel, Wolfgang Stremmel, Louis Griffel, Nicola Lynch, Yiyun Zhang, Antonello Pietrangelo   +17 more
openalex   +1 more source

Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients [PDF]

, 2010
Keith Tolley, Nick Oliver, Eliana Miranda, Kristen Migliaccio–Walle, Duygu Bozkaya, Q. Li   +5 more
openalex   +1 more source